BLSM BlossomHill Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $25.2M and sold $0 on the open market.
Recent BLSM insider trades
- Aug 10, 2026: Gordon Carl L bought 625,000 shares ($10.0M)
- Aug 10, 2026: Orbimed Advisors Llc bought 625,000 shares ($10.0M)
- Aug 10, 2026: Keyes Jason A bought 700 shares ($11.2K)
- Aug 10, 2026: Schmid John P. bought 6,000 shares ($96.0K)
5%+ owners
- Chen Bihua: 11.8% (Schedule 13D, filed Aug 13, 2026)
- ORBIMED ADVISORS LLC: 8.9% (Schedule 13D, filed Aug 18, 2026)
- Perceptive Advisors LLC: 5.9% (Schedule 13G, filed Aug 14, 2026)
- Vivo Innovation Fund II Holdings, L.P.: 5.5% (Schedule 13G, filed Aug 17, 2026)